Skip to content
PICO Portalanswers from OpenAlex

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

PaperCitations, authors & open-access status

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is a paper indexed in PICO Portal from OpenAlex.

How many citations does Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options have?

PICO Portalcitation count

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options has 31 citations in the OpenAlex counts PICO Portal stores.

When was Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options published?

PICO Portalyear

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options has 2022 year in the PICO Portal index.

What is the open-access status of Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

PICO Portaloa status

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options has diamond oa status in the PICO Portal index.

What is the DOI of Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

PICO Portaldoi

The DOI for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is on the source record.

What is the PMID of Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

PICO Portalpmid

The PMID for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is on the source record.

What is the OpenAlex record for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

PICO Portalopenalex

The OpenAlex for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial